美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Renaissance International IPO ETF

21.97

-0.2309-1.04%

成交量：4,466

成交額：9.86萬

市值：1,098.70萬

市盈率：- -

高：22.27

開：22.10

低：21.97

收：22.20

52周最高：26.25

52周最低：15.65

股本：50.00萬

流通股本：50.00萬

量比：2.53

換手率：0.89%

股息：0.15

股息率：0.66%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

萊美藥業(300006.SZ)子公司非奈利酮原料藥獲批上市

瓦軸B：擬向深交所申請主動終止股票上市

辰欣藥業(603367.SH)子公司藥品氯替潑諾妥布黴素滴眼液首仿獲批上市

破發股凱賽生物跌4.97% A股共募115億IPO中信證券保薦

破發股三元生物跌2.9% 上市即頂超募26億中信建投保薦

破發股威邁斯跌4.72% 上市即巔峯募20億東方證券保薦

宇樹科技跌1.49%創新低上個月上市募資61億元

辰欣藥業：子公司氯替潑諾妥布黴素滴眼液首仿獲批上市

萊美藥業：全資子公司獲得非奈利酮原料藥上市批准

彤程新材：董事會審議通過H股發行上市相關事宜

【新股IPO】海柔創新再推港股IPO進程龍頭光環下暗藏盈利與負債困境

港股異動 | 亮晴控股(03774)盤中升逾31% 公司轉主板上市兩月有餘本月初正式進入港股通名單

曝DeepSeek來了位90後CFO

智洋創新上半年虧損 2021上市募4.35億國聯民生保薦

秦川物聯扣非淨利連虧4年半 2020上市華安證券保薦

啱啱，閃崩！巨佬們扔出黑天鵝。。

納真科技開啓招股：全球AI光互連領域稀缺標的！

現代汽車集團高管表示，波士頓動力不太可能在2027年尋求IPO。

啱啱，閃崩！巨佬們扔出黑天鵝

大北農(002385.SZ)：未參與投資DeepSeek的上市融資

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IPOS/news?page=14"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":21.9739,"timestamp":1789588800000,"preClose":22.2048,"halted":0,"volume":4466,"delay":0,"changeRate":-0.010398652543594103,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"盤前交易","change":-0.2309,"latestTime":"09-17 04:43:50 EDT","open":22.1,"high":22.27,"low":21.97,"amount":98576,"amplitude":0.013511,"askPrice":34.93,"askSize":100,"bidPrice":9.9,"bidSize":14,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":21.9739,"sharesOutstanding":400001,"nav":22.2869,"aum":11143472.21,"dividendRate":0.006599,"bidAskSpread":0.005267,"postHourTrading":{"tag":"盘后","latestPrice":22.27,"preClose":21.9739,"latestTime":"16:10 EDT","volume":6,"amount":131.8434,"timestamp":1789589404236,"change":0.2961,"changeRate":0.013475,"amplitude":0},"volumeRatio":2.5303116290669214,"impliedVol":0.8998,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.5303116290669214,"shares":500001,"dividePrice":0.145,"high":22.27,"amplitude":0.013511,"preClose":22.2048,"low":21.97,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":21.9739,"committee":-0.754386,"eps":0,"divideRate":0.006599,"volume":4466,"delay":0,"ttmEps":0,"open":22.1,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":23.2152,"twentyDayClose":23.3147,"sixtyDayClose":26.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.10823,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:14,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667327659","title":"萊美藥業(300006.SZ)子公司非奈利酮原料藥獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667327659","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667327659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:14","pubTimestamp":1789373691,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司全资子公司重庆莱美隆宇药业有限公司(简称莱美隆宇)收到国家药品监督管理局核准签发的非奈利酮《化学原料药上市申请批准通知书》。非奈利酮是一种非甾体选择性盐皮质激素受体(MR)拮抗剂，其制剂用于治疗与2型糖尿病相关的慢性肾病成人患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659880","title":"瓦軸B：擬向深交所申請主動終止股票上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659880","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659880?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:14","pubTimestamp":1789373664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656246","title":"辰欣藥業(603367.SH)子公司藥品氯替潑諾妥布黴素滴眼液首仿獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656246","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656246?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:05","pubTimestamp":1789373101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，辰欣药业(603367.SH)发布公告，近日，公司子公司山东辰欣佛都药业股份有限公司(简称“佛都药业”)收到国家药品监督管理局核准签发的氯替泼诺妥布霉素滴眼液《药品注册证书》。氯替泼诺妥布霉素滴眼液注册分类为化学药品4类，主要用于治疗对类固醇有反应的眼部炎症，及其伴随的或潜在的眼表面细菌感染。佛都药业氯替泼诺妥布霉素滴眼液首次提交注册申请获得受理的时间为2025年，本次为国内首仿上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","603367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656273","title":"破發股凱賽生物跌4.97% A股共募115億IPO中信證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656273","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656273?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:01","pubTimestamp":1789372863,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 凯赛生物 今日收报37.88元，跌幅4.97%。该股目前处于破发状态。　　凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。　　上市首日，凯赛生物盘中最高价198元，为该股上市以来最高价。　　凯赛生物上述2次募集资金合计114.87亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2148510915.USD","LU2580892862.HKD","83130","600030","BK0196","BK0028","LU1781817850.SGD","LU2289578879.USD","LU1328615791.USD","BK4127","BK0208","83188","LU1146622755.USD","LU2580892789.USD","688065","LU1255011170.USD","BK0276","LU1064131003.USD","LU1655091616.SGD","KCE","LU2495084118.USD","LU1720050803.USD","IPOS","LU1997245094.SGD","LU1997245177.USD","07233","BK1516","BK1564","LU0405327148.USD","LU1794554557.SGD","02846","03188","BK1521","BK1147","REDS","02827","BK0012","159982","BK0188","06030","399300","BK0183","LU0405327494.USD","LU1580142542.USD","LU1820825898.SGD","LU1997244956.HKD","FRHC","82846","LU1064130708.USD","03130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667562226","title":"破發股三元生物跌2.9% 上市即頂超募26億中信建投保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2667562226","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667562226?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:01","pubTimestamp":1789372863,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 三元生物 今日股价下跌，截至收盘报24.14元，跌幅2.90%。　　上市首日，三元生物创下上市以来最高价报146.00元。　　三元生物首次公开发行股票的发行费用总额为1.39亿元，其中，保荐及承销费用1.21亿元。　　2022年6月10日，三元生物披露了2021年年度权益分派实施公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","601066","BK0276","301206","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667562786","title":"破發股威邁斯跌4.72% 上市即巔峯募20億東方證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2667562786","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667562786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:01","pubTimestamp":1789372862,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 威迈斯 今日收报37.75元，跌幅4.72%。该股目前处于破发状态。　　威迈斯于2023年7月26日在上交所科创板上市，发行股票数量4,210.00万股，发行价格为47.29元/股，保荐人为东方证券承销保荐有限公司，保荐代表人为王德慧、姜晓华。　　上市首日，威迈斯盘中最高价报62.00元，为该股上市以来最高价。　　威迈斯首次公开发行股票的发行费用合计15,509.36万元，其中，承销保荐费用11,547.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03958","BK0188","BK1147","BK0012","BK1564","IPOS","BK0028","600958","BK0264","688612","BK0183","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667220656","title":"宇樹科技跌1.49%創新低 上個月上市募資61億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667220656","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667220656?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:01","pubTimestamp":1789372862,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 宇树科技 今日盘中最低报465.58元，创上市以来股价新低。截至今日收盘，宇树科技报470元，跌幅1.49%。宇树科技上市首日开盘报1100元，若以上市当日开盘价买入宇树科技，今日收盘时亏损57.27%。　　宇树科技2026年8月19日在上交所科创板上市，发行股票数量4,044.6434万股，发行价格为150.80元/股。　　宇树科技本次发行募集资金总额609,932.22万元；扣除发行费用后，募集资金净额为591,714.92万元。宇树科技最终募集资金净额较原计划多171,543.8万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656123","title":"辰欣藥業：子公司氯替潑諾妥布黴素滴眼液首仿獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:00","pubTimestamp":1789372838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667699656","title":"萊美藥業：全資子公司獲得非奈利酮原料藥上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667699656","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667699656?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:57","pubTimestamp":1789372642,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667465666","title":"彤程新材：董事會審議通過H股發行上市相關事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2667465666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667465666?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:56","pubTimestamp":1789372588,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667493656","title":"【新股IPO】海柔創新再推港股IPO進程 龍頭光環下暗藏盈利與負債困境","url":"https://stock-news.laohu8.com/highlight/detail?id=2667493656","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667493656?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:54","pubTimestamp":1789372472,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所9月13日披露，海柔创新更新招股书，继续推进港股IPO上市进程，高盛、中信证券为联席保荐人。依托先发技术优势与持续迭代的产品体系，海柔创新在全球ACR市场的龙头地位持续巩固。截至2026年7月末，海柔创新的赎回负债达52.76亿元，占流动负债比例超过66.8%，而这笔负债每年产生的利息就将近2亿元，正持续侵蚀利润。海柔创新虽然在全球ACR市场占据超过30%的份额，但行业仍处于快速演变之中。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/YzZkNGQ5YjgxMTczNjIxODI3MDA4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YzZkNGQ5YjgxMTczNjIxODI3MDA4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991562","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRHC","BK4588","IPOS","VXUS","KCE","REDS","BK4127","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667492656","title":"港股異動 | 亮晴控股(03774)盤中升逾31% 公司轉主板上市兩月有餘 本月初正式進入港股通名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2667492656","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667492656?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:52","pubTimestamp":1789372341,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亮晴控股盘中涨超31%。消息面上，上交所近期宣布调整沪港通下港股通标的，亮晴控股正式进入港股通名单，已于9月7日起生效。值得注意的是，6月30日，亮晴控股成功从GEM转至主板上市。公司转主板两月有余便进入港股通名单，有助于进一步优化投资者结构、提升股票流动性及企业品牌价值。值得一提的是，今年7月，亮晴控股“AI抗衰老”平台开发启动，委聘香港AI企业Sunseeker开发模型。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","KCAI","03774","BK4588","BK1215","BK4585","FLHK","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667594236","title":"曝DeepSeek來了位90後CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667594236","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667594236?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:52","pubTimestamp":1789372320,"startTime":"0","endTime":"0","summary":"此前报道称，DeepSeek已聘请中信证券，为其科创板IPO筹备相关工作。9月14日消息，今日，据TOP华人科创社报道，高瓴创投90后合伙人严文韬或将加入DeepSeek出任CFO。倘若此事属实，这将成为DeepSeek创立以来，一次重量级的非技术高管引进。腾讯和宁德时代由此成为DeepSeek最大的外部股东。产品方面，DeepSeek的布局也已提速。资本、产品双线推进的同时，近段时间DeepSeek接连被曝出CFO即将就位、已聘请中信证券准备上市筹备配套工作，都预示其IPO进程正在提速。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-14/doc-inirutnu9432322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPO","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667565286","title":"智洋創新上半年虧損 2021上市募4.35億國聯民生保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2667565286","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667565286?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:47","pubTimestamp":1789372021,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 智洋创新 日前披露2026年半年度报告。报告期内，公司实现营业收入4.09亿元，同比减少11.57%；归属于上市公司股东的净利润-4592.32万元，上年同期为1907.88万元；归属于上市公司股东的扣除非经常性损益的净利润-4916.26万元，上年同期为1072.73万元；经营活动产生的现金流量净额650.64万元，上年同期为-4806.68万元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914922343.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914922343.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32368999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","01456","BK0231","BK1564","BK0276","601456","688191","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667565246","title":"秦川物聯扣非淨利連虧4年半 2020上市華安證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2667565246","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667565246?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:47","pubTimestamp":1789372021,"startTime":"0","endTime":"0","summary":"中国经济网北京9月14日讯 秦川物联 日前披露2026年半年度报告。　　秦川物联上市当日开盘报31.16元，盘中最高报34.00元，为该股上市以来最高价。　　秦川物联上市发行费用为5,922.06万元，其中华安证券获得承销保荐费用为4229万元。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914862959.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914862959.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260914/32369000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0225","688528","BK0183","BK0201","BK0276","IPOS","600909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667568536","title":"啱啱，閃崩！巨佬們扔出黑天鵝。。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667568536","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667568536?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:42","pubTimestamp":1789371754,"startTime":"0","endTime":"0","summary":"市场有三种猜测","market":"sg","thumbnail":"https://img3.gelonghui.com/4a340-bd156e62-d14d-4cd7-b05a-9aaeab5638b8.png?guru_height=383&guru_width=900&guru_size=376607","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/4a340-bd156e62-d14d-4cd7-b05a-9aaeab5638b8.png?guru_height=383&guru_width=900&guru_size=376607"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6641636","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["ARTY","IPOS","QTOC","AIPO","CHAT","AGIX","BK4588","VGT","VTHR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655612","title":"納真科技開啓招股：全球AI光互連領域稀缺標的！","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655612","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655612?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:26","pubTimestamp":1789370817,"startTime":"0","endTime":"0","summary":"前言：当AI算力需求从概念验证走向大规模基建落地，资本市场对光通信产业链的定价逻辑正在发生根本性切换。过去，市场倾向于将光模块企业视为跟随下游云厂商资本开支的周期型制造标的，给予较低估值中枢；而如今，具备‘芯模一体’垂直整合壁垒、全面转向","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6641115","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IPOS","CHAT","09856","AIPO","QTOC","AGIX","ARTY","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653762","title":"現代汽車集團高管表示，波士頓動力不太可能在2027年尋求IPO。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653762","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653762?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:09","pubTimestamp":1789369753,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["REDS","FRHC","BK4127","IPOS","KCE","EEMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655645","title":"啱啱，閃崩！巨佬們扔出黑天鵝","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655645","media":"ETF进化论","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:09","pubTimestamp":1789369742,"startTime":"0","endTime":"0","summary":"OpenAI可以为了安全暂停训练、推迟发布，甚至临时改掉研发路线。三位AI巨佬一边喊着减速，一边推迟IPO，等于亲手向市场扔出一只黑天鹅。OpenAI推迟IPO，更加重了这种猜测。第三种猜测，现在AI发展太迅猛，安全问题确实存在，这群AI巨佬们可能真的怕了。OpenAI称其为一记“警告枪”。对于AI巨佬们集体刹车这件事。这或许才是这场AI黑天鹅，最值得警惕的地方。","market":"fut","thumbnail":"http://imgcloud.jrjimg.cn/2026/09/weixin/one_20260914150921374.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/09/weixin/one_20260914150921374.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/09/14150958426644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["VGT","BK4588","BK4585","AIPO","CHAT","IPOS","AGIX","QTOC","VTHR","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667077653","title":"大北農(002385.SZ)：未參與投資DeepSeek的上市融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2667077653","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667077653?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:07","pubTimestamp":1789369621,"startTime":"0","endTime":"0","summary":"格隆汇9月14日丨大北农(002385.SZ)在互动平台表示，公司未参与投资DeepSeek的上市融资。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260914/32368939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","002385"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":14,"totalSize":1070,"code":"91000000","status":"200"}]}}